Fresh Recalls

FDAClass II · Drug · Recall D-0766-2026 · Recalled August 19, 2026

CLEAR EYES Maximum Itchy Eye Relief recall — Prestige Brands Holdings

Agency report date: August 19, 2026.

1. Compare your item

This notice names a product; your particular item is not yet verified. Compare every applicable model, serial, lot, production-date or model-year boundary below.

Product named
CLEAR EYES Maximum Itchy Eye Relief
Company / brand
Prestige Brands Holdings
Lot / serial / date codes
Lot 2552A, Exp 09/30/2027
Distribution
Nationwide in the USA.
Agency product description and boundaries

CLEAR EYES Maximum Itchy Eye Relief, 0.5 fl oz (15 mL) per dropper bottle, Sterile, Dist. by Medtech Products Inc., Tarrytown, NY 10591, a Prestige Consumer Healthcare Company. NDC: 67172-999-01 UPC 6 78112 65920 3

Still to verify: match the label on your item with the full official notice, including any exclusions, tables and photos. Some identifiers appear only on the agency website and are absent from this data feed. A missing field does not mean all versions are affected.

If your lot or date falls outside a stated range, this notice has not established that your item is affected. This is not a finding about other recalls or product safety.

2. Agency hazard and consumer action

FDA reports: Lack of assurance of sterility. The recall is due to potential contamination

No consumer remedy instructions are supplied in this record. Check the official notice and listed company contact for the agency’s current instructions.

Class II: may cause temporary or medically reversible health consequences.

Affected product: CLEAR EYES Maximum Itchy Eye Relief

3. Open the official notice or contact

Official recall ID
D-0766-2026
Brand
Prestige Brands Holdings
Classification
Class II
Units affected
39,060 15mL-bottles
Recall status
Ongoing
Initiated
Voluntary: Firm initiated

Affected products

Companies & origin

Recalling firm location
Tarrytown, NY, United States
Firm address
660 White Plains Rd, 10591-5139

Identifying details (verbatim from the notice)

Product codes / lots
Lot 2552A, Exp 09/30/2027
Distribution
Nationwide in the USA.
Firm notified the public via
Letter
FDA event ID
99532
Recall initiated
July 29, 2026
FDA classified
August 14, 2026
FDA report date
August 19, 2026
Verify with the official sources:

Found something wrong or missing? Report a data error.

Source: U.S. Food & Drug Administration. Agency excerpts come from the public data feed and may omit tables or later changes; the linked government source is authoritative. Source last checked September 7, 2026 at 6:00 AM UTC. Record retrieved September 7, 2026 at 6:00 AM UTC.

Report a data error on this page